| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $170.3M | -8.1% |
| Cost of Revenue | $75.6M | +30.5% |
| R&D Expense | $122.1M | -13.9% |
| SG&A Expense | $83.9M | -5.2% |
| Operating Income | -$227.0M | -13.4% |
| Interest Expense | $13.8M | +225.6% |
| Pre-tax Income | -$225.3M | -12.4% |
| Net Income | -$225.3M | -12.5% |
| EPS (Basic) | -$1.56 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.1M | -27.7% |
| Accounts Receivable | $38.0M | -5.2% |
| Inventory | $14.4M | -0.0% |
| Current Assets | $410.2M | -27.0% |
| Total Assets | $661.1M | -22.8% |
| Current Liabilities | $88.0M | -19.8% |
| Long-term Debt | $130.7M | +4.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$156.3M | +15.0% |
| Capital Expenditures | $10.7M | -34.6% |
| Investing Cash Flow | $129.6M | +4362.9% |
| Financing Cash Flow | $2.2M | -98.3% |
| Free Cash Flow | -$167.0M | +16.6% |
| -11.4% |
| EPS (Diluted) | -$1.56 | -11.4% |
| Total Liabilities |
| $352.9M |
| -10.1% |
| Stockholders' Equity | $308.4M | -33.6% |